Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testingWolff Schmiegel, Stephen B. Fox, Su Ping‐Chang et al.|Molecular Oncology|2017Cited by 161
When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in transMichelle W. Wong‐Brown, Rodney J. Scott, Mary McPhillips et al.|Hereditary Cancer in Clinical Practice|2016Cited by 6
P-273 Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testingRodney J. Scott, Stephen B. Fox, S Dooley et al.|Annals of Oncology|2015Cited by 1
The curious case of a woman with two BRCA1 mutations in transRodney J. Scott, Cliff Meldrum, Michelle W. Wong‐Brown et al.|Hereditary Cancer in Clinical Practice|2015Cited by 0
Meeting abstracts from the Annual Conference on Hereditary Cancers 2015Ella R. Thompson, Andrzej Pławski, Michelle W. Wong‐Brown et al.|Hereditary Cancer in Clinical Practice|2017Cited by 0